Status:
UNKNOWN
Clinical Re-evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy
Lead Sponsor:
Guangzhou University of Traditional Chinese Medicine
Conditions:
Intracerebral Hemorrhage
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
In order to investigate the time window of acute intracerebral hemorrhage(AICH) by "Blood Activating and Stasis Dispersing" therapy and to verify traditional methods if it would influence or enlarge t...
Detailed Description
objective: to investigate the safety and effect of acute cerebral hemorrhage treated with "Blood Activating and Stasis Dispersing" therapy and to verify the traditional methods can influence the brain...
Eligibility Criteria
Inclusion
- no younger than 18 yrs
- acute cerebral hemorrhage confirmed by brain CT scan
- within 6 hours from onset
- GCS≥6
- Sign the informed consent form
Exclusion
- Tests have confirmed that cerebral hemorrhage caused by brain tumor, blood diseases, cerebrovascular malformation (anomaly) or aneurysm, etc;
- patients with Severe heart, liver and renal insufficiency.
- Intolerance to traditional Chinese medicine (TCM), allergic constitution.
- patients with severe cerebral hernia in the early onset
- Compliance is poor.
Key Trial Info
Start Date :
October 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2016
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT01918722
Start Date
October 1 2013
End Date
December 1 2016
Last Update
March 11 2016
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong Provincial Hospital of Chinese Medicine
Guangzhou, Guangdong, China, 510120
2
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Guangzhou, Guangdong, China, 510120
3
Guangzhou Hospital of Integrated traditional and west medicine
Guangzhou, Guangdong, China, 510800
4
Panyu Hospital of Chinese Medicine
Guangzhou, Guangdong, China, 511400